Enquyst Technologies
Latest round
- Series B
Last raised
- Jun 2025
Total raised
- $6M
Investors
- 2
About Enquyst Technologies
Based in Massachusetts, US, and founded in 2017, Enquyst Technologies Inc, formerly known as Mobius Biomedical Inc. is a biologics manufacturing technology developer that primarily assists the biopharmaceutical industry in saving money and time. As of 2022, Vishal Jain is the Interim CEO of the company. The company is developing next-generation continuous biologics manufacturing technologies to bring unprecedented efficiencies in cost, time, footprint, and speed to market at the commercial scale for monoclonal antibody and gene therapy production. The firm’s technology reduces facility footprint, setup time, and cost, and provides the flexibility to manufacture biological drug products, as its flexible equipment modules are designed to enable continuous manufacturing of protein-therapeutics, RNA-therapeutics, and gene therapies. The organization plans to use the March 2022 investment to further expand its team and accelerate development.
Who invested in Enquyst Technologies
2 investors across 1 round
See all investors in Enquyst Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 4, 2025
Amount
$6M
Investors
Questions about Enquyst Technologies
Who invested in Enquyst Technologies?
Enquyst Technologies has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enquyst Technologies raised?
Enquyst Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Enquyst Technologies last raise money?
Enquyst Technologies's most recent round on record is a Series B, in Jun 2025.
What does Enquyst Technologies do?
Based in Massachusetts, US, and founded in 2017, Enquyst Technologies Inc, formerly known as Mobius Biomedical Inc.
Where is Enquyst Technologies headquartered?
Enquyst Technologies is headquartered in Lowell, US.
Which VCs invest in companies like Enquyst Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Enquyst Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Enquyst Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.